R Brett McQueen

Summary

Affiliation: University of Colorado Denver
Country: USA

Publications

  1. ncbi request reprint Increased relapse activity for multiple sclerosis natalizumab users who become nonpersistent: a retrospective study
    R Brett McQueen
    University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences, Anschutz Medical Campus, Mail Stop C238, 12850 E Montview Blvd, Aurora, CO 80045 Tel 303 709 9264 FAX 303 724 0979
    J Manag Care Spec Pharm 21:210-8. 2015
  2. doi request reprint Association between glycated hemoglobin and health utility for Type 1 diabetes
    R Brett McQueen
    Department of Clinical Pharmacy, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus, Mail Stop C238, 12850 E Montview Blvd, Aurora, CO, 80045, USA
    Patient 7:197-205. 2014
  3. pmc Cost-effectiveness of continuous glucose monitoring and intensive insulin therapy for type 1 diabetes
    R Brett McQueen
    Pharmaceutical Outcomes Research Program, School of Pharmacy, University of Colorado Denver, Aurora, Colorado, USA
    Cost Eff Resour Alloc 9:13. 2011
  4. doi request reprint Frequency of Continuous Glucose Monitoring Use and Change in Hemoglobin A1C for Adults with Type 1 Diabetes in a Clinical Practice Setting
    R Brett McQueen
    Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus, Aurora, Colorado
    Endocr Pract 20:1007-15. 2014
  5. ncbi request reprint Comparative effectiveness of early natalizumab treatment in JC virus-negative relapsing-remitting multiple sclerosis
    Jonathan D Campbell
    Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado, Aurora, CO 80045, USA
    Am J Manag Care 19:278-85. 2013
  6. pmc Fasting blood glucose--a missing variable for GFR-estimation in type 1 diabetes?
    Petter Bjornstad
    Department of Pediatrics, University of Colorado School of Medicine, Aurora, Colorado, United States of America
    PLoS ONE 9:e96264. 2014

Collaborators

Detail Information

Publications6

  1. ncbi request reprint Increased relapse activity for multiple sclerosis natalizumab users who become nonpersistent: a retrospective study
    R Brett McQueen
    University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences, Anschutz Medical Campus, Mail Stop C238, 12850 E Montview Blvd, Aurora, CO 80045 Tel 303 709 9264 FAX 303 724 0979
    J Manag Care Spec Pharm 21:210-8. 2015
    ..Few studies have estimated the association between real-world natalizumab persistence behavior and relapse-related outcomes...
  2. doi request reprint Association between glycated hemoglobin and health utility for Type 1 diabetes
    R Brett McQueen
    Department of Clinical Pharmacy, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus, Mail Stop C238, 12850 E Montview Blvd, Aurora, CO, 80045, USA
    Patient 7:197-205. 2014
    ..The cross-sectional relationship between HbA1c and health utility scores in adult type 1 diabetes patients was estimated after adjusting for diabetes-related complications...
  3. pmc Cost-effectiveness of continuous glucose monitoring and intensive insulin therapy for type 1 diabetes
    R Brett McQueen
    Pharmaceutical Outcomes Research Program, School of Pharmacy, University of Colorado Denver, Aurora, Colorado, USA
    Cost Eff Resour Alloc 9:13. 2011
    ..abstract:..
  4. doi request reprint Frequency of Continuous Glucose Monitoring Use and Change in Hemoglobin A1C for Adults with Type 1 Diabetes in a Clinical Practice Setting
    R Brett McQueen
    Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus, Aurora, Colorado
    Endocr Pract 20:1007-15. 2014
    ..To estimate the frequency of continuous glucose monitoring (CGM) use and change in hemoglobin A1c (HbA1c) compared to self-monitoring of blood glucose (SMBG) alone in adults with type 1 diabetes in a clinical practice setting...
  5. ncbi request reprint Comparative effectiveness of early natalizumab treatment in JC virus-negative relapsing-remitting multiple sclerosis
    Jonathan D Campbell
    Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado, Aurora, CO 80045, USA
    Am J Manag Care 19:278-85. 2013
    ..To estimate the long-term comparative effectiveness of first-line treatment in patients negative for anti-JC virus (JCV) antibodies with glatiramer acetate (GA), fingolimod, or natalizumab for relapsing-remitting multiple sclerosis (RRMS)...
  6. pmc Fasting blood glucose--a missing variable for GFR-estimation in type 1 diabetes?
    Petter Bjornstad
    Department of Pediatrics, University of Colorado School of Medicine, Aurora, Colorado, United States of America
    PLoS ONE 9:e96264. 2014
    ..We hypothesized that simultaneously measured blood glucose would influence eGFR in adults with T1D...